119 related articles for article (PubMed ID: 29195085)
1. Clinical and hematological profile in a newborn cohort with hemoglobin SC.
Rezende PV; Santos MV; Campos GF; Vieira LLM; Souza MB; Belisário AR; Silva CM; Viana MB
J Pediatr (Rio J); 2018; 94(6):666-672. PubMed ID: 29195085
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea therapy for pediatric patients with hemoglobin SC disease.
Miller MK; Zimmerman SA; Schultz WH; Ware RE
J Pediatr Hematol Oncol; 2001; 23(5):306-8. PubMed ID: 11464988
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea treatment of children with hemoglobin SC disease.
Yates AM; Dedeken L; Smeltzer MP; Lebensburger JD; Wang WC; Robitaille N
Pediatr Blood Cancer; 2013 Feb; 60(2):323-5. PubMed ID: 22949140
[TBL] [Abstract][Full Text] [Related]
4. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea therapy in children severely affected with sickle cell disease.
Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
[TBL] [Abstract][Full Text] [Related]
6. Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
Luchtman-Jones L; Pressel S; Hilliard L; Brown RC; Smith MG; Thompson AA; Lee MT; Rothman J; Rogers ZR; Owen W; Imran H; Thornburg C; Kwiatkowski JL; Aygun B; Nelson S; Roberts C; Gauger C; Piccone C; Kalfa T; Alvarez O; Hassell K; Davis BR; Ware RE
Am J Hematol; 2016 Feb; 91(2):238-42. PubMed ID: 26615793
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program.
Sabarense AP; Lima GO; Silva LM; Viana MB
J Pediatr (Rio J); 2015; 91(3):242-7. PubMed ID: 25449790
[TBL] [Abstract][Full Text] [Related]
8. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study.
Downes SM; Hambleton IR; Chuang EL; Lois N; Serjeant GR; Bird AC
Ophthalmology; 2005 Nov; 112(11):1869-75. PubMed ID: 16171867
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile of sickle cell disease in Orissa.
Kar BC; Devi S
Indian J Pediatr; 1997; 64(1):73-7. PubMed ID: 10771815
[TBL] [Abstract][Full Text] [Related]
10. Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.
Ghafuri DL; Chaturvedi S; Rodeghier M; Stimpson SJ; McClain B; Byrd J; DeBaun MR
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035747
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
12. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
[TBL] [Abstract][Full Text] [Related]
13. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE
J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
[TBL] [Abstract][Full Text] [Related]
14. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
15. Palpable splenomegaly in children with haemoglobin SC disease: haematological and clinical manifestations.
Zimmerman SA; Ware RE
Clin Lab Haematol; 2000 Jun; 22(3):145-50. PubMed ID: 10931162
[TBL] [Abstract][Full Text] [Related]
16. Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
Rigano P; De Franceschi L; Sainati L; Piga A; Piel FB; Cappellini MD; Fidone C; Masera N; Palazzi G; Gianesin B; Forni GL;
Blood Cells Mol Dis; 2018 Mar; 69():82-89. PubMed ID: 29107441
[TBL] [Abstract][Full Text] [Related]
17. The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial.
Wang W; Brugnara C; Snyder C; Wynn L; Rogers Z; Kalinyak K; Brown C; Qureshi A; Bigelow C; Neumayr L; Smith-Whitley K; Chui DH; Delahunty M; Woolson R; Steinberg M; Telen M; Kesler K
Br J Haematol; 2011 Mar; 152(6):771-6. PubMed ID: 21275961
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.
Tshilolo L; Tomlinson G; Williams TN; Santos B; Olupot-Olupot P; Lane A; Aygun B; Stuber SE; Latham TS; McGann PT; Ware RE;
N Engl J Med; 2019 Jan; 380(2):121-131. PubMed ID: 30501550
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.
Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
Pediatrics; 2008 Apr; 121(4):777-82. PubMed ID: 18381543
[TBL] [Abstract][Full Text] [Related]
20. [Breastfeeding and the anthropometric profile of children with sickle cell anemia receiving follow-up in a newborn screening reference service].
Nogueira ZD; Boa-Sorte N; Leite ME; Kiya MM; Amorim T; Fonseca SF
Rev Paul Pediatr; 2015; 33(2):154-9. PubMed ID: 25662563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
